Research ArticleHuman Studies
PET Hydroxyephedrine Imaging of Neuroblastoma
Barry L. Shulkin, Donald M. Wieland, Marie E. Baro, David R. Ungar, Deanna S. Mitchell, Mukund G. Dole, Jawhar B. Rawwas, Valerie P. Castle, James C. Sisson and Raymond J. Hutchinson
Journal of Nuclear Medicine January 1996, 37 (1) 16-21;
Barry L. Shulkin
Donald M. Wieland
Marie E. Baro
David R. Ungar
Deanna S. Mitchell
Mukund G. Dole
Jawhar B. Rawwas
Valerie P. Castle
James C. Sisson
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
PET Hydroxyephedrine Imaging of Neuroblastoma
Barry L. Shulkin, Donald M. Wieland, Marie E. Baro, David R. Ungar, Deanna S. Mitchell, Mukund G. Dole, Jawhar B. Rawwas, Valerie P. Castle, James C. Sisson, Raymond J. Hutchinson
Journal of Nuclear Medicine Jan 1996, 37 (1) 16-21;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Norepinephrine Transporter as a Target for Imaging and Therapy
- 123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma
- Imaging hNET Reporter Gene Expression with 124I-MIBG
- Whole-Body PET/CT with 11C-Meta-Hydroxyephedrine in Tumors of the Sympathetic Nervous System: Feasibility Study and Comparison with 123I-MIBG SPECT/CT
- The Human Norepinephrine Transporter in Combination with 11C-m-Hydroxyephedrine as a Reporter Gene/Reporter Probe for PET of Gene Therapy
- Neuroblastoma: A Disease Requiring a Multitude of Imaging Studies
- Technical Issues in Performing PET Studies in Pediatric Patients
- Extending Positron Emission Tomography Scan Utility to High-Risk Neuroblastoma: Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography as Sole Imaging Modality in Follow-Up of Patients